Quarterly report pursuant to Section 13 or 15(d)

SHARE BASED COMPENSATION (Details)

v3.5.0.2
SHARE BASED COMPENSATION (Details) - Restricted Stock
9 Months Ended
Sep. 30, 2016
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Non-vested, beginning balance, shares | shares 311,372
Vested, shares | shares (143,527)
Forfeited, shares | shares (2,120)
Non-vested, ending balance, shares | shares 508,638
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Non-vested, beginning balance, Weighted Average Grant Price (USD per share) | $ / shares $ 22.58
Vested, Weighted Average Grant Price (USD per shares) | $ / shares 22.15
Forfeited, Weighted Average Grant Price (USD per share) | $ / shares 24.23
Non-vested, ending balance, Weighted Average Grant Price (USD per share) | $ / shares $ 14.59
Non-employee directors  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Restricted stock awards granted, shares | shares 40,663
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Restricted stock awards granted Weighted Average Grant Price (USD per share) | $ / shares $ 10.59
Employees  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Restricted stock awards granted, shares | shares 302,250
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Restricted stock awards granted Weighted Average Grant Price (USD per share) | $ / shares $ 10.56